It was a big week for Duratec (ASX: DUR), winning four separate contracts representing a combined value of approximately $70M. The company signed a construction management contract at Orica’s Hunter Valley Hydrogen Hub (HVHH), alongside three additional contract awards across the Energy, Marine and the Mining & Industrial sectors. The HVHH contract represents a key step in Duratec’s expansion into future energy and fuel infrastructure markets, positioning the Company to support the broader energy transition and decarbonisation of industrial operations.

West African Resources (ASX: WAF) reported record high quarterly gold production of 125,179 ounces in Q2 2026, achieving a run-rate of more than 500,000 ounces per annum from its two large low-cost gold production centres of Sanbrado and Kiaka in Burkina Faso. Q2 gold sales of 110,737 oz at a realised price of US$4,556/oz generated cash flow from operating activities of A$249 million, for A$876 million cash balance and ~A$247 million unsold gold bullion held at end of Q2 2026. A replay of the company’s June quarterly conference call is available here.

Advanced Innergy Holdings (ASX: AIH) completed its acquisition of 100% of the issued share capital in Matrix Composites & Engineering LTD (ASX: MCE). Matrix has exported more than $1b in Australian-made composite goods to the global energy sector, and operates Australia’s largest composite manufacturing facility at Henderson, WA. AIH and Matrix will leverage complementary materials science capabilities, manufacturing footprints and customer networks to capture growth across deepwater oil and gas developments and emerging offshore markets.

Predictive Discovery (ASX: PDI) continued to deliver in the June quarter, with a strong focus on operational performance at the company’s Kiniéro and Nampala gold mines, advancing key development activities at Bankan and maintaining momentum across its broader portfolio. Kiniéro had average plant throughput of ~9.0Mtpa during the quarter, 50% above nameplate capacity, while gold recovery improved to 90.5% and 54,252oz Au was poured. Nampala also provided a solid contribution, pouring a further 9,774oz Au. AISC of US$1,408/oz was reported across both operations, with Kiniéro delivering strong cost performance at US$1,254/oz and Nampala at US$1,974/oz. Cash margin of US$112M reflected the strong cash generation at both the Kiniéro and Nampala gold mines.

Lycopodium (ASX: LYL) secured a Detailed Engineering Services contract by Pilgangoora Operations, a subsidiary of PLS Group, valued at ~$22m. The company will design the Wet Plant for PLS to progress to final investment decision (FID) for the P2000 Expansion Project and follows Lycopodium’s delivery of the Front-End Engineering Design (FEED) for the Wet Plant. The company has been working with PLS in the ongoing development of its flagship Pilgangoora Operation for a number of years.

Perseus Mining (ASX: PRU) delivered strong operational performance during the June quarter, with cash and bullion increasing to US$1 billion. Q4 FY26 production totalled 109,013 ounces of gold at an AISC of US$1,941 per ounce, average cash margin of US$2,145/oz of gold produced, delivering notional operating cashflow of US$216 million and a record US$769 million for the full FY26 financial year. Looking ahead, FY27 will be a transformational year for Perseus as the company brings two major growth projects — CMA Underground and Nyanzaga — through to commercial production alongside its existing operations. A replay of the company’s June quarterly conference call is available here.

Appen (ASX: APX) announced Q2 FY26 revenue of $65.1 million, up 26% on pcp, driven by continued momentum across its China and Global businesses. Appen China delivered another quarter of accelerating growth, with revenue up 75% to $41.3m vs pcp, supported by generative AI-related projects and the strength of relationships with Chinese model builders. Appen Global showed improving performance and revenue mix, as it expanded its relationships with leading AI labs and continued its adoption of AI across its operations.

Imricor Medical Systems (ASX: IMR) commenced its official U.S. commercial launch through Rady Children’s Hospital in San Diego. Rady’s Children purchased Imricor’s NorthStar interventional magnetic resonance (iMR) mapping and guidance system, and will be the the first U.S. hospital to commit to delivering cardiac catheterisation procedures guided by NorthStar in a 100% radiation-free iMR setting. Several additional U.S. hospitals are in the final stages of the purchasing process, and sales at these sites are expected over the coming weeks. From these results, Imricor expects Revenue from these NorthStar sales to exceed the aggregate full year revenue from the European business in 2025.

Join us for online event, The Future of Industrial Supply on 7 August 2026.

Global supply chains are being reshaped by changing geopolitics, energy security, decarbonisation and the growing demand for critical industrial inputs.

Join us as Argonaut's Sarah Kerr provides the keynote outlook on the key macro trends shaping industrial supply chains, before hearing from five ASX-listed companies operating across the sectors driving the next generation of industrial supply.

Speakers:

• Sarah Kerr, Argonaut – Macro outlook & industrial supply chains
• Will Barker, Equus Energy (ASX: EQU) – Natural Gas
• Glenn Corrie, Hazer Group (ASX: HZR) – Ammonia, Hydrogen & Graphite
• Dr Krista Davies, Prominence Energy (ASX: PRM) – Natural Hydrogen & Helium
• Daniel Gleeson, Canadian Phosphate (ASX: CP8) – Phosphate & Fertiliser
• Aaron Banks, Green360 Technologies (ASX: GT3) – Construction Materials (Fly, Ash and Slag)

Each company will present its investment thesis while providing insight into the supply chain trends shaping its sector, followed by a live investor Q&A.

📅 Thursday, 7 August

🕚 11:00am AEST

Register here: https://us02web.zoom.us/webinar/register/WN_jhZTk7mjSyysuOfibtsAYA

Join us for the next event in our NWR Melbourne Resources Lunch series when we showcase presentations by Broken Hill Mines (ASX: BHM); Chariot Resources (ASX: CC9), Green Technology Metals (ASX: GT1); Connected Minerals (ASX: CML) and Green360 Technologies (ASX: GT3).

📅 Thursday, 13 August 2026

🕚 Presentations commence at 12pm AEST, refreshments to follow

📍 QT Hotel , 133 Russell St, Melbourne

🔗 Register here

Several analysts released updated research on West African Resources (ASX: WAF) following the company’s record high June quarterly gold production. Canaccord’s latest report has a $5.75/share target on WAF: “At the group level, WAF delivered record quarterly production of 125koz and remains on track to achieve 2026 guidance of 430-490koz at AISC <US$1,900/oz,” analyst Paul Howard wrote. “YTD production is 233koz at US$1,823/oz AISC, highlighting the benefit of having two operating production centres. WAF's balance sheet remains strong, in our view. Cash and bullion increased to A$1.12bn at the end of the JunQ'26 from A$1.06bn at the end of March, representing a 6% increase QoQ.”

Euroz Hartleys raised its target to $5.70/share (from $5.55/share): “Another excellent Q result from WAF, with net cash up after growth capex and government payments, and production and costs tracking well to guidance,” analyst Mike Millikan wrote. “WAF remains materially undervalued given its production profile and cash generation, with the Burkina Faso published decree to acquire 25% of Kiaka for A$176m removing some uncertainty. The strong FCF generation in CY26-27 is expected to support early debt repayment and provide capital returns via dividends and/or buybacks. We now assume a ~20cps dividend in CY26 (~46% payout ratio, ~7% yield).”

Argonaut’s latest report has a $5.60/share target: “WAF’s 2QCY26 production result of 125.2koz had been pre-reported, which was 8% higher than our estimates at the time,” analyst Patrick Streater wrote. “Reported AISC for 2QCY26 was better than expected, although cash and bullion build was only modest (6%) for 2QCY26 following higher income taxes and minority payments versus our estimates. Key short-term catalysts for WAF include a potential capital return to shareholders to be announced in the 2HCY26, along with permitting progress for the Kiaka explosives facility and the M5 South underground. Buy rating maintained.”

Macquarie maintained its $4.00/share target: “FCF generation remains strong, with minimal production impacts over the near term,” analyst Regan Burrows wrote. “Shareholder returns and/or buybacks targeted for 2H CY26. Our target price is maintained at $4.00, and we retain our Outperform recommendation.”

Evolution Capital updated coverage on BLS Pharmaceuticals (ASX: BLS) maintaining its SPEC BUY recommendation and increasing its price target to $1.60/share (from $1.50/share) following a record FY26 result, with revenue and EBITDA both landing at the top end of management guidance. The higher valuation reflects stronger cash generation, the removal of a previously forecast equity raising, and continued confidence in the company's growth outlook.

METALS AND MINING

Aurum Resources (ASX: AUE) reported further intercepts from drilling at BDT2 at its Boundiali Gold Project in Cote d’Ivoire which included 0.61m @ 47.60 g/t Au from 189.39m and 0.50m @ 35.19 g/t Au from 90.0m. These results, from the final batch of drilling at the BDT2 deposit, intersected gold mineralisation outside the current Mineral Resource and extended the deposit at depth. Aurum expects to update the Boundiali MRE in Q3 CY2026 after completing 100,000m of drilling.

Auric Mining (ASX: AWJ) announced the outcomes of the Integrated Burbanks and Munda Scoping Study, which support re-establishment of the Burbanks processing facility and the restart of mining at Munda in WA’s Goldfields region. Re-establishment of Burbanks provides a clear pathway to becoming a standalone integrated gold producer. Covered by Sydney Morning Herald, Mining.com.au, MiningNews.net. Auric also commenced a major RC drilling program at Munda focused on infill and resource extension, aiming to add ounces to the open pit development targeting 2.7Mt at 1.75g/t Au for 155koz outlined in the Scoping Study.

Australian Mines (ASX: AUZ) commenced a fast-tracked Pre-Feasibility Study for its Flemington Scandium Project in NSW, expanding the study to assess the potential to increase annual scandium oxide production from 60 tonnes to up to 180 tonnes. With a new drilling program to test resource extensions and provide additional metallurgical samples, the PFS builds on the project's recently completed Scoping Study, which outlined a post-tax NPV₈ of up to US$860 million, a 74% IRR, and a 28-year mine life based on Flemington's 6.3Mt at 446ppm scandium Mineral Resource. Covered by Mining Weekly and Stockhead

Cue Energy (ASX: CUE) commenced drilling at the PV14 appraisal well in the Palm Valley gas field in the Northern Territory, the first of a two-well program designed to evaluate and develop additional gas resources. The program is expected to take around 4.5 months, with first gas from PV14 targeted for October 2026. If successful, the drilling has the potential to more than double current field production, restore plant sales capacity and support long-term gas supply under the recently secured Northern Territory Government Gas Sales Agreement through to 2034.

Canadian Phosphate (ASX: CP8) commenced resource drilling at its Wapiti Phosphate Project in British Columbia, Canada as it looks to generate a new MRE for the project later this year. A resource estimate is expected to underpin future mining, processing and economic studies for Wapiti, and drilling will also support metallurgical studies to assess Wapiti’s suitability for Single Super Phosphate (SSP) fertilizer production, and organic and regenerative agricultural phosphate products.

Enova Mining (ASX: ENV) commenced resource delineation drilling at its Naked Hill Rare Earth Project in Brazil. The current program comprises 198 auger holes to be completed in three phases to define the extent and continuity of saprolite-hosted rare earth mineralisation and support a maiden resource while integrated mineral characterisation and hydrometallurgical test work is progressing. Covered by Mining Technology. It also confirmed high-value magnetic rare earth mineralisation at its Santo António do Jacinto Project in Brazil, with initial auger drilling intersecting near-surface saprolite-hosted mineralisation averaging 25% NdPr.

Heavy Rare Earths (ASX: HRE) provided an update following the Company’s previous announcement dated 20 July 2026 and titled ‘Strategic Review Highlights Heavy Rare Earths at Subron (formerly Cowalinya)’.The update includes all significant drill intervals exceeding 1,000ppm TREO together with the associated REO distribution (MREO and HREO), detailed assays for individual lanthanides within intervals greater than 1,000ppm TREO, a complete drill collar table for all drill holes returning more than 1,000ppm TREO, and a compliance statement relating to the Company’s mineral resource.

American Tungsten & Antimony (ASX: AT4) executed a Share Sale and Purchase Agreement to acquire 100% of the Del Sol Refinery in Nevada and the White Spar Antimony Mine in Arizona. The refinery has scope for expansion into production of ammonium paratungstate (APT) and higher value antimony products, including Regulus II antimony metal, antimony trisulphide, and sodium antimonate. The proposed acquisition includes acquiring 100% of the White Spar Antimony Mine that currently feeds the Del Sol Refinery. Covered by mining.com.au

Clean Teq Water (ASX: CNQ) completed commissioning and contractual performance testing for its first full-scale commercial PHOSPHIX® phosphate removal plant, delivered in partnership with Enva in Ireland. This completion milestone establishes the Company's first commercial operating reference for PHOSPHIX® and provides a platform for future European growth.

Iltani Resources (ASX: ILT) reported assay results from RC drillholes ORR160 to ORR164 & ORR166, completed as part of the 110 drill hole program underway at the company’s Orient Silver-Indium Project. Drill holes ORR160, ORR162, ORR164 & ORR166 at Orient East returned multiple intercepts of high-grade silver-lead-zinc-indium mineralisation, and ORR164 intercepted two zones (Upper and Lower) of high-grade silver-rich mineralisation, with both zones containing exceptional grades.

Everest Metals (ASX: EMC) provided an operational update on the Mt Dimer Taipan Gold Project, where mining, grade control drilling, and ROM stockpiling activities continue to advance as the Company progresses toward processing under its toll-treatment agreement.

Rock chips at Perpetual Resources’ (ASX: PEC) Paraíba Tungsten Project in northeastern Brazil confirmed high-grade tungsten mineralisation across three separate target areas, with a peak result of 1.53% WO₃ and six of the 18 samples returning assays above 0.50% WO₃. The results strengthen Perpetual’s strategy to build a portfolio of high-quality tungsten assets across Tier-1, Western-aligned mining jurisdictions.

Falcon Metals (ASX: FAL) secured regulatory approvals for the maiden RC drilling program at the Olsen Well Prospect in WA, with drilling targeted to commence this quarter. Rock chip sampling has confirmed bedrock gold mineralisation, returning up to 6.42g/t Au within a 5.8km-long gold-in-soil anomaly, while the project has also been expanded to more than 60km of strike along the prospective Errabiddy Shear Zone. Covered by Australian Resources and Investment

Novo Minerals (ASX: LMS) provided an update on its planned H2 2026 exploration programs at the Tibooburra Gold Project, NSW. A ~2,700m RC drilling program is scheduled to commence at Tibooburra in late Q3 2026 post receipt of all regulatory and landholder approvals. Drilling is planned to test the Clone (~1,700m) and Pioneer South prospects (~1,000 m).

INDUSTRIAL

Orbital Corporation (ASX: OEC) secured an order from US autonomous cargo aircraft developer MightyFly for three Orbital HFE propulsion systems, with deliveries scheduled for September 2026. Two engines will support MightyFly's flight test program and one will be used for ground-based development, as the company advances its autonomous cargo aircraft toward commercial deployment. The order expands Orbital's commercial customer base and provides exposure to the growing autonomous middle-mile cargo market. Coverage via SmallCaps

MAXIParts Limited (ASX: MXI) provided an update on its anticipated FY26 financial results based on unaudited management accounts, together with details of recent Executive Team appointments.

Metal Powder Works (ASX: MPW) received an initial purchase order for pure copper powder used in an add-mix application by Advantage Metal Powders Inc. It marks MPW’s first production order in the press-and-sinter (P&S) market, demonstrating MPW’s strengthening market position and the flexibility and high-efficiency of MPW’s Direct Powder Technology.

ECS Botanics (ASX: ECS) announced the planned mid-August launch of two new all-in-one vape products, expanding its branded direct-to-consumer portfolio through a capital-efficient consignment arrangement. Covered by Cannabiz

Babylon Pump & Power (ASX: BPP)announced the sale of its maintenance business, sharpening its focus on its core water management rental operations as part of its strategic simplification.

ENERGY

Prominence Energy (ASX: PRM) outlined a capital-efficient pathway toward mid-2027 helium and natural hydrogen drilling in South Australia. Gravity and magnetic data work through July will define leads and prospects, with independent Prospective Resources Reviews due for the Eyre Project by end-August and Northern Hinge Project by end-September. Drilling engineering and cost estimates follow in October, ahead of detailed 2027 program design in November and December. Initial costings point to roughly three wells for ~$5m, with options to farm-out or partner to reduce capital exposure.

TECHNOLOGY

Acusensus (ASX: ACE) extended its existing agreement with the State of Queensland for the provision of mobile phone and seatbelt enforcement technology. Queensland’s Department of Transport and Main Roads exercised the first of two twelve month extension options, and the incremental contract value associated with the extension is expected to total ~$4.3m.

Cyclopharm (ASX: CYC) secured a significant endorsement for Technegas, with newly published international lung imaging guidelines naming it as the preferred ventilation imaging agent, the first update to US guidance in 14 years. Jointly published by four leading nuclear medicine societies across the US, Europe and ANZ, the guidelines support a shift to three-dimensional SPECT and SPECT/CT imaging, recognise applications beyond pulmonary embolism, including CTEPH, COPD, asthma and lung cancer, and are expected to accelerate adoption across US hospitals and health systems. The company believes the endorsement strengthens its US commercial opportunity by supporting broader institutional uptake of Technegas and reinforcing its long-term growth strategy in AI-enabled functional lung imaging.

Advanced Braking Technology (ASX: ABV) reported record quarterly product sales revenue of $6.2 million in Q4 FY26, up 10.7% on the prior corresponding period, reflecting continued demand for the Company’s safety-critical braking solutions, supported by disciplined execution, a growing installed base and ongoing momentum across both domestic and international mining markets. Unaudited total revenue for FY26 was $23.5m, up from $19.1m in FY25. Normalised unaudited net profit before tax (NPBT) for Q4 FY26 was $652k, up 81.0% on the pcp.

RAS Technology (ASX: RTH) announced a new agreement with Tabcorp to supply market-leading data and content, including RAS’ Fast Form service. The agreement value is $9.1 million plus indexation over the four-year term. Under the agreement, RAS supplies content, analytics, and predictive models to Tabcorp to support their digital, retail and vision assets.

Dataworks Group (ASX: DWG) reported positive operating cashflow of $538k for the June quarter and $276k for FY26, with record customer receipts and the successful launch of its second government Centralised Self-Exclusion platform for responsible gambling in Ontario.

BIOTECH

Neurotech International (ASX: NTI) strengthened the clinical evidence supporting NTI164, with results from its Phase II/III HARMONY Study in children with autism spectrum disorder accepted for publication in the leading peer-reviewed journal Neurotherapeutics. The publication validates the company's 54-patient, randomised, double-blind, placebo-controlled trial, which demonstrated clinically meaningful and statistically significant improvements across multiple validated measures with an excellent safety profile, further enhancing the credibility and visibility of NTI164 among clinicians, researchers and potential commercial partners.

Saluda Medical (ASX: SLD) announced Q4 FY26 revenue of US$27.0 million, up 43% on pcp, delivering FY26 full-year revenue of US$90.2 million, up 28% and exceeding guidance of US$87.0 million. The Company received FDA approval for its CAP24™ paddle lead, expanding the Evoke® System into surgical procedures, with first US surgical cases completed in July. Saluda also continued scaling its US sales force and physician education programs with a 23% growth in active physician utilisation, supporting the broader adoption of its closed-loop neuromodulation platform.

InteliCare (ASX: ICR) has expanded its commercial agreement with Hardi Aged Care, following upgrades to Hardi’s Blacktown facility with the addition of 84 beds. Hardi has also made the strategic decision to undertake a phased deployment of InteliCare’s Nurse Call system across all its facilities, with two of these deployments underway (Blacktown and Manly Vale). InteliCare’s commercial momentum continues with deployments progressing across mecwacare and Warrigal, in addition to Hardi, supporting growth in recurring SaaS revenue. The Company recorded $1.8 million in cash receipts in the last quarter, generating positive cash for the quarter of $384,000 – its first period of positive cashflow since listing.

CORPORATE NEWS

KGL Resources (ASX: KGL) completed its 1 for 1.29 non-renounceable entitlement offer of new fully paid ordinary shares in KGL, as announced on Thursday, 25 June 2026. The Entitlement Offer will raise a total of ~A$120 million (before costs) at the offer price of A$0.20 per New Share. The Entitlement Offer was undertaken in conjunction with a conditional placement to raise ~A$180 million (before costs), which remains subject to shareholder approval. In total, the Entitlement Offer and the Conditional Placement will raise ~A$300 million.

Lakes Blue Energy (ASX: LKO) completed a $4.0 million placement and launched a partially underwritten 1-for-4.7 entitlement offer to raise a further $4.7 million, taking total proceeds to approximately $8.7 million at $0.30 per share. The entitlement offer opens Friday, 7 August 2026 and closes Tuesday, 18 August 2026. Funds will advance the Wombat Project, including perforation, stimulation and flow testing to target near-term cash flow. Separately, Boyd White has resigned from the board effective on completion of the raise, with Hugh Walter Robertson appointed as non-executive Director.

Radiopharm Theranostics (ASX: RAD) has received firm commitments for an approximately A$12.5 million institutional capital raising to Australian and international institutional and sophisticated investors. The Placement is being followed by an SPP to raise up to A$6 million for existing eligible shareholders. Capital raising proceeds will fund the preparation and readiness to commence the RAD101 registrational Phase 3 study, the completion of RAD 204 dose escalation, while progressing RAD 202, RAD 402 & RV01 therapeutic programs and supporting ongoing strategic partnering initiatives.

Golden Dragon Mining (ASX: GDR) completed a share placement for $2.2m to Chengtun Gold Limited totalling 11,000,000 fully paid ordinary shares at an issue price of A$0.20 per share. Placement price represented a 15% premium to the five-day VWAP. Funds will go to accelerating exploration at the Cue Gold Project.

Chimeric Therapeutics (ASX: CHM) secured A$1.62 million in early funding through an advance against its anticipated FY26 Research and Development Tax Incentive (RDTI), strengthening its near-term funding position. The proceeds will support the company's ongoing Phase 1/2 clinical trials, general working capital and strategic review, while replacing an existing R&D funding facility that has now been fully repaid. The funding provides Chimeric with additional financial flexibility as it advances its portfolio of clinical-stage cell therapy programs.

Connected Minerals (ASX: CML) received shareholder approval for the proposed acquisition of the Frontier Group, which holds an 80% interest in the highly prospective Bailundo Carbonatite Project in Angola. Angola's National Mineral Resources Agency has granted an expansion of the Bailundo mineral rights to include niobium, rare earth elements and phosphates, aligning the licence with the project's carbonatite-hosted critical minerals potential. Covered by Australian Resources and Investment

Stockhead's Barry Fitzgerald covered Tungsten Mining (ASX: TGN) in a report noting tungsten prices have surged tenfold over the past year to more than US$3000/mtu on China's export restrictions, fuelling investor interest in ASX tungsten miners. TGN is advancing two near-term developments, Watershed (Qld) and Mt Mulgine (WA), targeting first production in 2027 and 2029.

Cannabiz covered ECS Botanics (ASX: ECS), reporting on the challenges that all medicinal cannabis suppliers are facing in new requirements set by German regulators.

Energy World Corporation (ASX: EWC) was mentioned in the New York Times, noting LNG's role in helping the Asian energy market to transition from coal.

Burley Minerals (ASX: BUR) Pilbara Update Investor Presentation

Hazer Group (ASX: HZR) Investor Presentation

Radiopharm Theranostics (ASX: RAD) Capital Raising Investor Presentation

Firebrick Pharma (ASX: FRE) TechKnow Presentation

Larvotto Resources (ASX: LRV) Noosa Mining Investor Presentation - Recording

ECS Botanics (ASX: ECS) Q4 FY26 Investor Presentation

Prominence Energy (ASX: PRM) Chief Operating Officer Dr Krista Davies discussed with Sharewise's Wei Sim why the opportunity in helium and natural hydrogen is emerging now, and the leverage and positioning Prominence holds across these two strategically important resources. 

Evergold Minerals (ASX: EG1) Non-Executive Director Glenn Grayson joined Mining.com.au outlining the company’s systematic approach to testing its sanukitoid (intrusive-related) geological model - a target style similar to major multi-million-ounce deposits in the surrounding region.

Pilbara Gold (ASX: PGL) Managing Director Dr Peter Turner discussed the first results from Pilbara Gold's biggest-ever Mt York drill campaign with Mining News.

BOA Resources (ASX: BOA) MD Graeme Purcell joined Matt Michael from the LEVRD podcast to discuss the Company's transformation into an emerging copper explorer following the acquisition of the Thaduna and Green Dragon copper assets. Graeme discusses the company’s strategy to consolidate ownership of the Neds Creek copper project, the significance of acquiring granted Mining Leases from Sandfire Resources, and the potential of BOA’s 121kt contained copper resource. The conversation also explores BOA's upcoming 15,000m drill program, the opportunity to expand resources at depth, and the key catalysts investors can expect through 2026 and beyond.

Larvotto Resources (ASX: LRV) Managing Director Ron Heeks provided an update on the Hillgrove Antimony-Gold Project to Mining.com.au at the Noosa Mining Conference.

Ark Mines (ASX: AHK) Chair Roger Jackson discussed upcoming catalysts for the Sandy Mitchell Rare Earths Project in Queensland with Mining.com.au at the Noosa Mining Conference.

Kalamazoo Resources (ASX: KZR) Chair Luke Reinehr discussed progress at Ashburton Gold Project with Shae Russell from Mining.com.au.

Green360 Technologies (ASX: GT3) Executive Chairman Aaron Banks sat down with Stockhead’s Tylah Tully to discuss a big quarter of executed deals and operational advancements as the company looks towards consistent cash flow positivity and addressing one of the biggest structural opportunities in Australian construction.

ECS Botanics (ASX: ECS) highlighted its successful shift to higher-margin direct-to-consumer medicinal cannabis sales in its latest investor webinar, with strong cash flow improvement following major capex and growing international opportunities across Germany, New Zealand and Poland.